Intervention not reported
Parasite prevalence (21‐ to 25‐month · adults and childen living in malaria‐endemic areas, Anopheles gambiae complex or Anopheles funestus group
The intervention probably leads to lower parasite prevalence (21‐ to 25‐month (moderate certainty).
1 finding from 1 review
Intervention not reported
Mosquito mortality (unwashed nets) · adults and childen living in malaria‐endemic areas, Anopheles gambiae complex or Anopheles funestus group
The intervention leads to higher mosquito mortality (unwashed nets) (high certainty).
1 finding from 1 review
Intervention not reported
Mosquito mortality (washed nets) · adults and childen living in malaria‐endemic areas, Anopheles gambiae complex or Anopheles funestus group
It is very uncertain whether the intervention changes mosquito mortality (washed nets) (very low certainty).
1 finding from 1 review
Intervention not reported
Blood‐feeding success (unwashed nets) · adults and childen living in malaria‐endemic areas, Anopheles gambiae complex or Anopheles funestus group
The intervention leads to lower blood‐feeding success (unwashed nets) (high certainty).
1 finding from 1 review
Intervention not reported
Blood‐feeding success (washed nets) · adults and childen living in malaria‐endemic areas, Anopheles gambiae complex or Anopheles funestus group
The intervention leads to lower blood‐feeding success (washed nets) (high certainty).
1 finding from 1 review
Intervention not reported
Mosquito mortality (unwashed nets) · Anopheles gambiae complex or Anopheles funestus group
The intervention probably leads to higher mosquito mortality (unwashed nets) (moderate certainty).
1 finding from 1 review
RR 1.68 [1.33, 2.11]
Studies not reported
Moderate
Intervention not reported
Overall survival ( · people with relapsed or refractory DLBCL
1 finding from 1 review
Intervention not reported
Quality of life ( · people with relapsed or refractory DLBCL
1 finding from 1 review
Intervention not reported
Any adverse events ( · people with relapsed or refractory DLBCL
1 finding from 1 review
Intervention not reported
Any serious adverse events ( · people with relapsed or refractory DLBCL
1 finding from 1 review
Intervention not reported
Cytokine release syndrome ( · people with relapsed or refractory DLBCL
1 finding from 1 review
Intervention not reported
Progression‐free survival ( · people with relapsed or refractory DLBCL
1 finding from 1 review
Intervention not reported
Complete response ( · people with relapsed or refractory DLBCL
1 finding from 1 review
Intervention not reported
Dental caries prevalence
1 finding from 1 review
Intervention not reported
Dental caries prevalence
1 finding from 1 review
Death Analysis 1.1 · healthy asymptomatic H. pylori‐infected individuals
H. pylori eradication therapy showed no clear difference in death from all causes ‐ modified ITT analysis compared with control (moderate certainty).
1 finding from 1 review
Incidence of oesophageal squamous cell carcinoma ‐ modified ITT analysis · healthy asymptomatic H. pylori‐infected individuals
H. pylori eradication therapy showed no clear difference in incidence of oesophageal squamous cell carcinoma ‐ modified ITT… compared with control (moderate certainty).
1 finding from 1 review
Adverse events · healthy asymptomatic H. pylori‐infected individuals
1 finding from 1 review
Intervention not reported
Treatment failure day‐28 PCR‐adjusted(PP population) · children aged 14 years or younger with uncomplicated P falciparum malaria
The intervention showed no clear difference in treatment failure day‐28 PCR‐adjusted(PP population) (low certainty).
1 finding from 1 review
Intervention not reported
Treatment failureday‐28 PCR‐adjusted(ITT population) · children aged 14 years or younger with uncomplicated P falciparum malaria
The intervention showed no clear difference in treatment failureday‐28 PCR‐adjusted(ITT population) (low certainty).
1 finding from 1 review